Sensex: 73,832.55 (2.30%)

Nifty: 23,622.90 (1.99%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

Nse Announcement
Company Announcement
Aarti Pharmalabs Limited Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Accuracy Shipping Limited Accuracy Shipping Limited has informed the Exchange regarding Resignation of Mr. Raj Kumar Poddar as Non- Executive Independent Director of the company w.e.f. Jun 12, 2026.
Advent Hotels International Limited Karim Gulamali Morani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Advanced Enzyme Technologies Limite Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
Aequs Limited Aequs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Affle 3i Limited Affle 3i Limited has submitted to  the Exchange a copy of Disclosure under Regulation 31 (1) SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 - Revised
Authum Investment & Infrastructure Alpana Dangi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Ajanta Pharma Limited Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference
Ansal Properties & Infrastructure L The Company has informed the stock exchanges that the 53rd meeting of the committee of creditors of Fernhill Project of the Company situated at District Gurgaon, Haryana, is scheduled to be held on the 15th June, 2026.
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.